Publizoom

INCYTE BIOSCIENCES IBERIA, S.L.

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
3
Amount won alone
€1,565,801 excl. VAT
Shared contracts
1 (multi-supplier framework agreements)
Period
2 September 2026 – 19 October 2026

Its main clients

Where and what

Supplies · 3

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
14 April 2028
re-tender around October 2027		 26Far019 b)suministro de medicamentos "exclusivos" (i)
CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL 		BAYER HISPANIA S.L.U.
BOEHRINGER INGELHEIM ESPAÑA, S.A.
CASEN RECORDATI, S.L.
Esteve Pharmaceuticals, S.A.
EUROMED PHARMA SPAIN SL
GLAXOSMITHKLINE, S.A.
INCYTE BIOSCIENCES IBERIA, S.L.
JANSSEN CILAG S.A.
1 bid received		 €540,765
18 May 2028
re-tender around November 2027		 CBAM 578/2025 INCYTED/01
SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA 		INCYTE BIOSCIENCES IBERIA, S.L.
1 bid received		 €865,385

Contracts won

DateContractBuyerAmount
19/10/2026 26Far019 b)suministro de medicamentos "exclusivos" (i) CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL €540,765
shared by 8
07/10/2026 CBAM 578/2025 INCYTED/01 SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA €865,385
02/09/2026 Suministro de los productos farmacéuticos Levatinib, Pemigarinib, Ruxolitinib y Evinacumab para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria Consejería de Sanidad del Gobierno de Canarias €700,417

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.